MedPath

Prostate cancer and diet - a randomized controlled trial on the effect of a dietary intervention on the quality of life of men and serum nutrient levels in their blood.

Recruiting
Conditions
Prostate cancer
prostate carcinoma
10038588
10036958
Registration Number
NL-OMON50679
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
255
Inclusion Criteria

- Male, age >= 18 years.
- Diagnosed with prostate cancer.
- Currently being treated for prostate cancer (including active surveillance).
Has been treated for prostate cancer in the past.
- Able to understand and read Dutch

Exclusion Criteria

- Unable to understand and read Dutch.
- Unable to invest time in cooking according to the provided prostate cancer
diet.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>For the VERS+-group we expect an improved quality of life as measured with the<br /><br>SF-12, general health domain (improvement of ±5 points). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- For the VERS+-group an improved Patient Activation Measure (PAM) score is<br /><br>expected. Because the use of the PAM is still scarce in prostate cancer<br /><br>patients, it is difficult to quantify the expected score increase.<br /><br>- An increase in the nutrient levels measured in the blood of participants in<br /><br>the two intervention groups after 3 weeks (t2) and 3 months (t3) of following a<br /><br>prostate cancer diet.<br /><br>- To survey the user behaviour of both participants and their partners when<br /><br>engaging in a prostate cancer diet.<br /><br>- To test the infrastructure of greenkeepers in the Westland, producing and<br /><br>delivering products for a specific, targeted patient population instead of the<br /><br>general public. </p><br>
© Copyright 2025. All Rights Reserved by MedPath